| 注册
首页|期刊导航|中国医学装备|瑞舒伐他汀与普罗布考联合用药在颈动脉粥样硬化斑块治疗中的应用价值

瑞舒伐他汀与普罗布考联合用药在颈动脉粥样硬化斑块治疗中的应用价值

刘国勤

中国医学装备Issue(8):92-94,95,4.
中国医学装备Issue(8):92-94,95,4.DOI:10.3969/J.ISSN.1672-8270.2015.08.029

瑞舒伐他汀与普罗布考联合用药在颈动脉粥样硬化斑块治疗中的应用价值

Effect of rosuvastatin combination probucol on patients with carotid atherosclerotic plaque

刘国勤1

作者信息

  • 1. 成都市新华人民医院神内科 四川 成都 610067
  • 折叠

摘要

Abstract

Objective:To analyze the effect of rosuvastatin combination probucol on patients with carotid atherosclerotic plaque.Methods:Chosen patients with carotid atherosclerotic plaque in our hospital as research subjects, randomly assigned to control group received probucol alone and observation group received rosuvastatin combined probucol, compared IMT and OX-LDL levels inflammatory factors levels, incidence of adverse. Results:1)Observation group patients’ IMT and ox-LDL levels after treatment were significantly lower than control group patients(t=4.327,t=5.783;P<0.05); 2)Observation group patients’ hs-CRP, IL-6 and MMP-9 levels after treatment were significantly lower than control group patients (t=6.422,t=5.184,t=5.291;P<0.05); 3)Follow-up of 5 years, observation group patients vascular occlusion, plaque off , brain stem rate were significantly lower than control group patients (x2=4.827, x2=5.894,x2=5.937;P<0.05).Conclusion: Rosuvastatin can effectively reduce joint Probucol carotid atherosclerosis intima-media thickness sclerosis patients and reduce the level of oxidized LDL, inflammatory cytokines optimization, and ultimately reduce the incidence of adverse events, with positive clinical significance.

关键词

颈动脉粥样硬化/瑞舒伐他汀/普罗布考

Key words

Carotid atherosclerosis/Rosuvastatin/Probucol

分类

医药卫生

引用本文复制引用

刘国勤..瑞舒伐他汀与普罗布考联合用药在颈动脉粥样硬化斑块治疗中的应用价值[J].中国医学装备,2015,(8):92-94,95,4.

中国医学装备

OACSTPCD

1672-8270

访问量0
|
下载量0
段落导航相关论文